Study compares two lupus drugs: which works better for kidneys?
NCT ID NCT07031674
Summary
This study looked back at medical records to compare how well two existing drugs (telitacicept and belimumab) work for controlling lupus-related kidney inflammation. Researchers analyzed data from 56 adults who had already taken one of these drugs for at least 12 weeks. The goal was to see which medication was more effective and safer at reducing kidney damage and protein in urine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.